Clonal analysis of Notch1-expressing cells reveals the existence of unipotent stem cells that retain long-term plasticity in the embryonic mammary gland. by Lilja, Anna M et al.
  1
Clonal analysis of Notch1-expressing cells reveals the existence of 1 
unipotent stem cells that retain long-term plasticity in the embryonic 2 
mammary gland 3 
Anna M. Lilja#1,2, Veronica Rodilla#1,2^,*, Mathilde Huyghe1,2, Edouard Hannezo3,4,5,°, Camille 4 
Landragin1,2, Olivier Renaud1,2,6, Olivier Leroy1,2,6, Steffen Rulands7,8, Benjamin D. Simons3,4,5 5 
and Silvia Fre1,2*± 6 
#these authors contributed equally 7 
*corresponding authors 8 
±Lead contact: silvia.fre@curie.fr 9 
 10 
1Institut Curie, PSL Research University, INSERM, CNRS, F-75248 Paris Cedex 05, France. 11 
2Sorbonne University, UPMC University of Paris VI, F-75005, France. 12 
3Cavendish Laboratory, Department of Physics, University of Cambridge, United Kingdom 13 
4The Wellcome Trust/Cancer Research UK Gurdon Institute, University of Cambridge, UK 14 
5The Wellcome Trust/Medical Research Council Stem Cell Institute, University of Cambridge, 15 
UK 16 
6Cell and Tissue Imaging Facility (PICT-IBiSA), Institut Curie, 75005 Paris, France 17 
7Max Planck Institute for the Physics of Complex Systems, Noethnitzer Str. 38, 01187 Dresden 18 
Germany 19 
8Center for Systems Biology Dresden, Pfotenhauer Str. 108, 01307 Dresden, Germany 20 
^Current address: Preclinical Research Program; Vall d'Hebron Institute of Oncology (VHIO), 21 
08035 Barcelona, Spain 22 
  2
°Current address: Institute of Science and Technology Austria, Am Campus 1, 3400 23 
Klosterneuburg, Austria 24 
 25 
Abstract 26 
Recent lineage tracing studies revealed that mammary gland homeostasis relies on unipotent stem 27 
cells. However, whether and when lineage restriction occurs during embryonic mammary 28 
development and which signals orchestrate cell fate specification remain unknown. Using a 29 
combination of in vivo clonal analysis with whole mount immunofluorescence and mathematical 30 
modelling of clonal dynamics, we found that embryonic multipotent mammary cells become 31 
lineage restricted surprisingly early in development, with evidence for unipotency as early as 32 
E12.5 and no statistically discernable bipotency after E15.5. To gain insights into the 33 
mechanisms governing the switch from multipotency to unipotency, we used gain-of-function 34 
Notch1 mice and demonstrated that Notch activation cell autonomously dictates luminal cell fate 35 
specification to both embryonic and basally committed mammary cells. These functional studies 36 
have important implications for understanding the signals underlying cell plasticity and serve to 37 
clarify how reactivation of embryonic programs in adult cells can lead to cancer. 38 
 39 
Introduction 40 
Due to its unique capacity for rapid growth and regeneration, the mammary gland represents an 41 
ideal system to study stem cell plasticity and lineage specification, and their contribution to tissue 42 
morphogenesis and remodelling. The mammary epithelium is initially specified at embryonic day 43 
E11.5 as a skin placode, after which signals from surrounding ERα-expressing stromal cells 44 
direct the formation of spherical mammary buds1. The mammary buds invaginate into the 45 
underlying mesenchyme and after E15.5, they start invading the fad pad precursor and organise 46 
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into primitive tubular structures that develop into small rudimentary trees shortly before birth, at 47 
E18.52. During puberty, serial rounds of ductal branching and elongation lead to the specification 48 
of a complex branched epithelial network3,4. The mammary ductal tree is composed of two 49 
epithelial compartments: cells facing the ductal lumen are polarized cuboidal epithelial cells that 50 
constitute the luminal epithelium (called luminal cells or LC), while cells found in the outer 51 
layer, in contact with the basal membrane, are myoepithelial cells, which express Smooth Muscle 52 
Actin (SMA) conferring contractile capacity, termed basal cells (BC). Luminal cells can be 53 
further subdivided in two populations, depending on their expression of the hormone receptors 54 
Estrogen-α (ERα) and Progesterone (PR).  55 
Pioneering studies explored the capacity of single mammary cells to reconstitute a functional 56 
gland when orthotopically transplanted in the cleared fat pad of host mice, and defined a small 57 
subset of basal cells as multipotent mammary stem cells (MaSC)5,6, assumed to be responsible for 58 
the homeostatic maintenance of the tissue throughout adult life. .However, more recent lineage 59 
tracing studies based on targeted promoters generated conflicting data on whether mammary 60 
multipotent cells truly exist during development and adult reproductive life in vivo, or whether 61 
lineage-restricted progenitors are induced to behave in a multipotent manner following 62 
transplantation7-11. Lineage tracing provides the means to identify stem cells and track their 63 
progeny in vivo and in situ, by genetically labelling stem cells in their physiological niche, so that 64 
their derived daughter cells retain marker expression. Indeed, clonal analyses using specific 65 
promoters for genes expressed either in the luminal or in the basal compartment of the mammary 66 
epithelium, have shown that all mammary stem cells show unipotency in vivo during puberty and 67 
adulthood8,10,12-18. However, none of these prior studies has carefully examined how embryonic 68 
MaSCs contribute to postnatal development. Although some findings support the existence of 69 
multipotent stem cells during embryogenesis8,11,18, as population-based studies, the question of 70 
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whether individual embryonic stem cells exhibit multipotent potential at the clonal level or 71 
comprise distinct cell subsets already committed toward a specific cell lineage remains unsolved. 72 
The Notch signalling pathway has been linked to stem cell maintenance and cell fate 73 
specification in many tissues and it has been shown to promote luminal differentiation in the 74 
mammary gland19. Through clonal analysis of Notch1-labelled cells in the pubertal gland, we 75 
have previously demonstrated that the Notch1 receptor labels exclusively ERα-negative (ERαneg) 76 
luminal progenitors. Notch1-expressing mammary cells are strictly unipotent in adult mice, but 77 
surprisingly can give rise to a progeny composed of all types of mammary cells in transplantation 78 
experiments or when tracing is initiated in embryos, demonstrating cell plasticity11. These results 79 
are in agreement with other studies showing that different glandular epithelia (mammary gland, 80 
prostate, sweat glands) initially develop from multipotent SCs, which are progressively replaced 81 
by unipotent progenitors during post-natal development8,11,20-22. Here, we used our Notch1-82 
CreERT2 mouse line (N1CreERT2)23 to genetically mark embryonic mammary cells and tracked 83 
their progeny throughout development, to define the developmental timing for the acquisition of 84 
mammary cell identity and lineage commitment. As the use of a single-colour reporter can lead to 85 
misinterpretation of lineage tracing results, because clones derived from distinct lineage-86 
committed progenitors could be merged when analysed in the post-natal gland, we have used the 87 
multicolour Confetti reporter mouse and whole mount imaging of the ductal tree, to genetically 88 
map the fate of mammary cells during the first wave of mammary development and branching, 89 
starting at embryonic day E12.5. Mathematical modelling of our experimental data clearly 90 
indicated the presence of unipotent cells committed to a unique lineage already in the E12.5 91 
embryonic mammary bud, thus remarkably early in mammary gland morphogenesis. 92 
Surprisingly, embryonic mammary cells from E15.5 onwards do not seem to retain multilineage 93 
potential in vivo, although they are still undifferentiated cells, which will acquire a basal or 94 
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luminal identity only at birth. In addition, to define the mechanisms regulating the observed 95 
restriction in lineage potential during mammary development, we have used Notch1 gain-of-96 
function mice, and found that intrinsic cell autonomous signals can impose a specific cell fate to 97 
both embryonic and post-natal lineage-restricted mammary cells. These functional studies have 98 
important implications for understanding stem cell plasticity and lineage potential in vivo and to 99 
explore the possibility that reactivation of embryonic developmental programs in adult cells 100 
could lead to cancer24-26. 101 
 102 
Results 103 
 104 
Mammary basal and luminal identities are defined at birth 105 
To induce clonal labelling at early developmental times, pregnant N1CreERT2 mice crossed to a 106 
double fluorescent reporter line (R26mTmG)27 (henceforth called N1Cre/mTmG) were induced 107 
using a low dose of tamoxifen (0.1mg/g of mouse body weight). Analysis of marked cells 24h 108 
following Cre induction at E13.5 and E15.5, revealed that the Notch1 receptor is expressed in 109 
most of the cells comprising the mammary bud, as also demonstrated by Notch1 in situ 110 
hybridisation (Supplementary Fig. 1a), all of which express both basal and luminal markers (K5, 111 
K14 and p63 for basal cells, BCs and K8 for luminal cells, LCs) (Fig. 1; Fig. 4a-b), consistently 112 
with previous reports1,28-32. When we examined the progeny derived from these cells after a 6-113 
week chase, we found that embryonic Notch1pos mammary cells, at the population level, give rise 114 
to both BCs (CD24+/CD29high) and LCs (CD24+/CD29low) (Fig. 2a) in a comparative proportion 115 
to that observed in unlabelled mammary epithelial cells (MEC) (Fig. 2c), indicating that cells 116 
targeted by the Notch1 promoter in embryogenesis show no lineage bias. Representative dot plots 117 
to illustrate the gating strategy are shown in Supplementary Fig. 1b. 118 
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To define the developmental timing of mammary cell identity acquisition, we induced 119 
N1CreERT2/R26mTmG mice at different developmental times and analysed their progeny in the 120 
pubertal gland. While embryonic induction of GFP expression resulted in GFP-labelled lineages 121 
that included both BCs and LCs, from post-natal day P3 onwards, Notch1-derived cells were 122 
exclusively luminal, as assessed both by FACS quantification and by immunostaining (Fig. 123 
2a,c,e). Consistently, tracing clonal lineages derived from a basally expressed Cre line, Acta2-124 
CreERT2 (called SMA-Cre)33, revealed that SMA-expressing basal cells labelled at birth 125 
exclusively gave rise to basal progeny (Fig. 2b,d,f). These results indicate that, for the vast 126 
majority of MaSCs (if not all), mammary luminal and basal identities are resolved at birth, and 127 
that BCs and LCs represent distinct and self-sustained lineages throughout adult life. 128 
Interestingly, within the luminal lineage, Notch1pos embryonic cells can give rise to both ERαpos 129 
(Scapos/CD133pos) and ERαneg (Sca-/CD133-) daughter cells, at an unbiased ratio when compared 130 
to total LCs (Supplementary Fig. 2a). As Notch1 expression is restricted to ERαneg unipotent 131 
luminal progenitors in 4 week-old pubertal mice11, we traced post-natal cells by inducing mice at 132 
different developmental times and found that Notch1 expression becomes progressively restricted 133 
to ERαneg cells (Sca-/CD133-) shortly before puberty, between 2 and 3 weeks of age 134 
(Supplementary Fig. 2b). Importantly, when we assessed if single Notch1-expressing LCs 135 
labelled at birth could give rise to both ERαpos and ERαneg cells using the multicolour Confetti 136 
reporter mouse34, we found that clones of luminal cells labelled by the same colour were 137 
exclusively composed of either ERαpos or of ERαneg cells (Supplementary Fig. 2c). These results 138 
indicate that luminal cells are composed of two distinct lineages maintained by unipotent luminal 139 
progenitors, in agreement with two recent studies demonstrating that ERαpos and ERαneg luminal 140 
cells represent two independent lineages maintained by distinct stem cells in adult mice35,36. 141 
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Therefore, the N1CreERT2 line labels different types of mammary cells: undifferentiated cells in 142 
the embryo, luminal cells after birth (from P3 to P21) and exclusively ERαneg luminal progenitors 143 
at the onset of puberty (after P21) and allowed us to infer the critical developmental times for 144 
mammary lineage specification, an unexplored and important question to define how cell identity 145 
is specified and how the adult mammary cell types are determined during development. 146 
Notch1pos embryonic mammary cells reveal unipotent cell fate potential in early 147 
mammogenesis 148 
To determine whether embryonic MaSC exhibit bipotency at the cellular level and, if so, when 149 
this potential is lost during development, we crossed N1CreERT2 mice to the multicolour Confetti 150 
reporter line to trace the fate of individual mammary cells, imaging whole mount mammary 151 
glands of two-week-old mice, after induction during embryogenesis (from E12.5 to E17.5). Due 152 
to extensive cell rearrangements occurring during branching morphogenesis10,13,14, clones derived 153 
from embryonic labelling were composed of scattered cells throughout the gland. Our 154 
multicolour strategy was chosen with the aim of distinguishing clones derived from different 155 
stem cells, as they would be marked stochastically by one of the four colours resulting from the 156 
initial recombination event.  157 
To resolve individual clonal events, we scored all cells labelled by the same Confetti colour 158 
throughout the whole gland. Strikingly, even with these very strict criteria, we found a high 159 
proportion of unicolour cell clusters (“unipotent clones”), belonging exclusively to the basal or 160 
luminal lineage (Fig. 3b, GFP and YFP labelled cells), which increased at late embryogenesis, 161 
suggesting that some cells acquire unipotency as early as E12.5 (Supplementary Fig. 5a). Since 162 
cells of the same colour could appear in the basal and luminal compartments through the chance 163 
induction of distinct unipotent progenitors (“chance bipotency” in Fig. 3c), we used a statistical 164 
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method10 designed to assess the existence and relative abundance of true bipotent clones. For 165 
each induction time point, we tested the null hypothesis that all seemingly bipotent events arose 166 
by chance induction of independently labelled unipotent cells. This was achieved by simulating 167 
the stochastic labelling of unipotent LC and BC progenitors, taking into account three measured 168 
parameters: 1) the recombination efficiency, fit based on the average abundance of floxed colours 169 
per gland, both initially (Fig 3a,e and Supplementary Fig. 3) and after a longer chase (Fig. 3b,d 170 
and Supplementary Fig. 4-5); 2) the fraction of each recombined colour and 3) the relative 171 
frequency of luminal and basal induction. All three parameters were validated for robustness (see 172 
Theory Methods and Supplementary Fig. 5d-m for details). 173 
The observed percentages of bipotent clones were then compared with the theoretical probability 174 
of “chance bipotency” (Fig. 3c-d)10. As shown in Fig. 3d, the null hypothesis could not be 175 
rejected (at 95% confidence level) at E15.5 and E17.5, meaning that “chance bipotency” could 176 
account for all observed bipotent events. This suggests that, after E15.5, Notch1pos embryonic 177 
mammary cells do not show significant multilineage potential in vivo (see Theory Methods and 178 
Supplementary Fig. 5b-k). By contrast, the probability of “chance bipotency” accounted for only 179 
one half of the experimentally observed bipotency at E12.5 and E13.5, indicating that multipotent 180 
cells are present at these embryonic stages. Importantly, as the recombination efficiency 181 
(parameter 1) is a key input of the model, we validated it by performing short-term tracing, 182 
measuring the number of labelled singlets and doublets, which well correlated with the inferred 183 
recombination efficiency from the long-term tracing (Fig. 3f). These results suggest that 184 
progressive restriction in lineage potential occurs as early as E12.5, whereas mammary 185 
embryonic cells from E15.5 onwards present no evidence for a significant multipotent behaviour, 186 
despite co-expressing basal and luminal markers, and continuing to contribute to both lineages 187 
until birth (Fig. 1 and Fig.2a,c). 188 
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Notch1 dictates luminal ERαneg cell fate in embryogenesis 189 
To investigate whether embryonic cell fate is controlled by internal signals or by 190 
environmental/positional cues, we targeted Notch1-expressing cells from the early embryo 191 
(E13.5) to puberty with a transgenic line allowing constitutive Notch1 activation (Rosa-N1ICD-192 
IRES-nGFP)37. We induced the mosaic expression of the ligand-independent active form of the 193 
Notch1 receptor (Notch1 Intracellular Domain or N1ICD) and found that cells expressing active 194 
Notch1 exclusively give rise to LC (Fig. 4d,e,g), and specifically of the ERαneg 195 
(Sca1neg/CD133neg) lineage (Fig. 5a,b), at any developmental stage (from E13.5 to P3), including 196 
when induction is performed in embryonic cells. Of note, embryonic cells expressing N1ICD still 197 
co-express luminal and basal markers and do not seem to undergo substantial changes in 198 
epithelial cell morphology 48h after Notch activation (Fig 4a-c). Moreover, no statistically 199 
significant differences could be observed in their proliferative activity within 48h, compared to 200 
control N1CreERT2/R26mTmG cells (Fig 5c, d). Surprisingly, when we targeted mammary 201 
embryonic cells with the N1CreERT2/N1ICD line, we could not observe any difference in 202 
epithelial layer integrity and in the ratio between LCs and BCs compared to N1CreERT2/R26mTmG 203 
mice after a 6-week chase (Supplementary Fig. 6a), suggesting a possible compensation from 204 
untargeted wild type cells. Although Notch1 is also expressed in some stromal cells during 205 
embryogenesis (Fig. 1, Supplementary Fig. 6b-e), Notch1 constitutive activation did not affect 206 
these cells even after a 6-week chase (Supplementary Fig. 6c-e). These results demonstrate that 207 
intrinsic signals can dictate a switch from multipotency to unipotency and that Notch1 signalling 208 
instructs embryonic mammary cells to differentiate exclusively as luminal ERαneg cells (Fig. 5e). 209 
Ectopic Notch1 activation can switch the fate of committed mammary epithelial cells 210 
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Although our lineage tracing results, consistent with other studies performed using different 211 
promoters8,10,13-18, have established that the postnatal mammary gland harbours exclusively 212 
unipotent stem cells, recent works revealed the considerable plasticity of mammary stem cells 213 
upon oncogenic induction or following transplantation8,11,15,38. We thus assessed the plasticity of 214 
fully committed pubertal cells, by ectopic activation of the Notch pathway, an essential critical 215 
determinant of luminal cell fate specification (Fig. 4-5 and Ref.19). To this end, we ectopically 216 
expressed the constitutively active form of Notch1 in committed basal cells using two basal Cre 217 
lines, SMA-CreERT2 and K5-CreERT2 39, crossed to Rosa-N1IC-IRES-nGFP mice. Strikingly, 218 
ectopic Notch1 activation in BCs (SMACre/N1ICD and K5Cre/N1ICD) at the onset of puberty is 219 
sufficient to entirely switch their identity to ERαneg LCs (Fig. 6). Interestingly, the switch from 220 
basal to luminal ERαneg cells occurs progressively, since a 3-week chase after induction at P21 221 
(P21+3w) still presents some labelled basal cells, but a 6-week chase demonstrated a complete 222 
shift from basal to luminal ERαneg cells (P21+6w) (Fig. 6a,b,d,e and Supplementary Fig. 7). The 223 
same cell fate switch was obtained when different types of BCs16 were targeted, using either 224 
SMA-CreERT2 or K5-CreERT2 (Fig. 6c,d,e), demonstrating that Notch signalling impacts lineage 225 
specification at different levels of the basal cell hierarchy. To characterise how the observed cell 226 
fate switch occurs in time, we have analysed the cellular responses to Notch activation in mice 227 
where N1ICD expression was induced for different chase periods, compared to control mice. We 228 
observed that some cells acquire a luminal position already during the first week after Notch1 229 
activation (P21+72h and P21+1w in Supplementary Fig. 7b) and co-expression of luminal and 230 
basal keratins (K8 and K14) is notable in some cells that migrated towards the duct lumen 231 
(indicated by an arrow in panel P21+3w of Supplementary Fig. 7b), while it takes 6 weeks before 232 
the cell fate switch is complete (P21+6w, Fig. 6 and Supplementary Fig. 7). 233 
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Since no major differences in terms of proliferation or apoptosis were observed in GFPpos cells 234 
after N1ICD induction (Supplementary Fig. 7b), we sought for mechanistic insights underlying 235 
the observed cell fate switch, by performing a whole-genome transcriptomic analysis of cells 236 
expressing N1ICD 72h after induction (in the SMACre model), to detect the early transcriptional 237 
responses to Notch activation. As expected, we found an upregulation of Notch target genes (Fig. 238 
7a). Remarkably, we clearly identified by Gene Set Enrichment Analysis (GSEA) a highly 239 
significant reduction in expression of genes belonging to the “Mammary Stem Cell UP” gene 240 
signature within genes downregulated in the targeted cells (GFPpos) (Fig.7c-d). This signature 241 
represents genes highly expressed in BCs, defined as “Mammary stem cells” based on their high 242 
mammary repopulation capacity in transplantation assays40. In addition, Extracellular Matrix and 243 
Epithelial-to-Mesenchymal Transition (EMT) gene signatures, features that have been associated 244 
with BCs41, were also significantly downregulated upon Notch activation. Overall, by both GO 245 
analysis (Fig. 7c) and Gene Set Enrichment Analysis (GSEA) (Fig. 7d), we reveal that GFPpos 246 
cells negatively correlate with a basal signature, indicating that they lose their basal identity 247 
before they acquire a definitive luminal signature, as the increased expression of luminal cell 248 
markers (namely luminal cytokeratins K8, K18 and K19) is evident, but not yet statistically 249 
significant after only 72h of Notch activation. 250 
These results show that the unipotency of mammary stem cells belies a remarkable degree of 251 
plasticity that allows cell autonomous factors to redirect cell identity and differentiation potential, 252 
irrespective of the cellular environment (i.e. contact with the basement membrane) and the degree 253 
of commitment of the targeted cells. 254 
 255 
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Discussion 256 
We showed that early embryonic development of the mouse mammary gland relies on the 257 
proliferative activity of multipotent stem cells that progressively differentiate into lineage-258 
restricted unipotent precursors that fuel post-natal growth. Of relevance, Blanpain and colleagues 259 
have observed a similar switch from multipotency to unipotency during the course of embryonic 260 
development, using K14 and K5 lineage tracing experiments46. Statistical analysis of lineage 261 
labelled cells suggests that Notch1pos mammary cells have become restricted to generate basal or 262 
luminal progeny by E15.5 (Fig. 7e). Although we cannot exclude the existence of embryonic 263 
quiescent bipotent cells29 that are not targeted by N1CreERT2, the representative composition of 264 
bipotent clones labelled by the N1CreERT2 line prior to E15.5 reflects the general tissue growth 265 
both in cell proportion and composition, providing support to the concept that we are assessing 266 
the generic behaviour of the majority of embryonic cells. Therefore, our studies suggest that, if 267 
such cells exist, they must be rare and act in parallel to the cells expressing the Notch1 receptor, 268 
while the bulk of mammary embryonic growth proceeds from a population of unipotent basally 269 
and luminally-committed progenitors. Lineage potential restriction coincides with the initiation 270 
of branching morphogenesis around E15.5, suggesting that the two processes might be linked, 271 
possibly through mechano-sensitive pathways, though the mechanisms underlying lineage 272 
restriction in this context still remain unknown.  273 
It has been previously reported that surface ectodermal cells can integrate into the mammary bud 274 
at the early times of bud invagination42. Notably, we could observe a high number of GFPpos 275 
cells in the prospective surface epidermis (see Fig. 4a and Supplementary Fig. 6b). This is not 276 
surprising, as the Notch1 receptor has been reported to be expressed in the early embryonic 277 
epidermis, where it is required for regulating epidermal keratinocyte specification43. Whether 278 
embryonic skin and mammary stem cells, due to their common origin from an ectodermal 279 
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progenitor and the fact that they both specify ectodermal appendages, may share some 280 
characteristics and may be regulated by the same molecular pathways, such as Notch signalling 281 
repressing p63 in both epithelia, is a possibility that is worth considering.  282 
Our findings also reveal the extensive and durable plasticity of basal mammary stem cells. The 283 
mechanisms used by stem cells to acquire a specific identity and lineage potential are the same as 284 
those that can be hijacked by oncogenes to induce cellular transformation in several tissues44, so 285 
their elucidation is also relevant to understand the origin of cancer. Here, we show that Notch 286 
activation can impose a cell fate switch on both undifferentiated (with N1CreERT2/N1ICD mice 287 
induced during embryogenesis, Fig. 5e) and committed (with SMACreERT2/N1ICD mice induced 288 
at P21, Fig. 6e) mammary cells, driving a progressive transition into unipotent ERneg luminal 289 
progenitors (Fig. 7e). In the accompanying paper, Blanpain and colleagues observed a 290 
complementary cell fate switch induced by expression of ΔNp63 in either embryonic or 291 
committed luminal cells46. As ΔNp63 has been shown to be negatively regulated by Notch 292 
signaling in the mammary gland45, our two studies describe mechanisms dictating cell fate 293 
specification in the mouse mammary gland. Indeed, such events may constitute a key early-stage 294 
of pre-neoplastic transformation, leading to mammary tumors development. Undoubtedly, the 295 
expression of intrinsic determinants should result from the exposure of individual cells to distinct 296 
environmental cues; it follows that the position that each embryonic cell acquires during tissue 297 
morphogenesis (i.e. their contact with the basement membrane or their facing the ductal lumen) 298 
might also contribute to establishing its identity as a BC or LC and to limit its lineage potential. 299 
Future investigations would be required to further understand the dynamic behaviour and 300 
plasticity of embryonic MaSCs.  301 
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Figure Legends 443 
Figure 1. Embryonic mammary buds co-express luminal and basal markers. Representative 444 
sections of mammary embryonic buds of N1Cre/mTmG embryos induced with tamoxifen at 445 
E13.5 (a, b, c, upper panel, d, e), or at E15.5 (c lower panel) and analysed 24h later by: 446 
hematoxylin coloration (a); immunostaining using an anti-ERα antibody (in red in b); 447 
immunofluorescence for the luminal marker K8 (in red, in c and d, upper panel) and the basal 448 
markers K14 (in white in c and in red in e, upper panel); K5 (in red, bottom panel in d); and 449 
p63 (in red, lower panel in e). GFPpos cells in green represent N1Cre-labelled embryonic cells in 450 
b-e. DAPI stains the nuclei in blue in c, e. Split channels for each colour are shown in the inset 451 
magnifications in c-d. 3 individual embryos for induction at E13.5 and 3 individual embryos for 452 
induction at E15.5. Scale bars correspond to 20 μm in b-e, and 10 μm in the magnifications in c-453 
e. 454 
Figure 2. Luminal and basal identities are specified at birth. a-b. Representative FACS dot 455 
plots of luminal (LC) and basal cells (BC) gated within the GFPpos population in N1Cre/mTmG 456 
(a) or SMACre/mTmG (b) mice 6 weeks after tamoxifen induction at E13.5 (a) or at P3 (a-b) 457 
quantified in c and d. c-d. FACS quantification of GFPpos BC (in green) as compared to the 458 
proportion of BC within Mammary Epithelial Cells (MEC, in orange) in N1Cre/mTmG (c) or 459 
SMACre/mTmG (d) mice, 6 weeks after tamoxifen induction at the indicated developmental 460 
times; n=5, 4, 5, 3 and 6 independent mice for N1Cre/mTmG induced at E13.5, E15.5, E17.5, 461 
P0.5 (MEC: 19.01±2.27, GFP: 95.45±2.26) and P3 (MEC: 25.67±1.37 and GFP: 99.56±0.06), 462 
respectively; n=7 and 2 biologically independent animals for SMACre/mTmG induced at P0.5 and 463 
P3, respectively. Schematic diagrams of the Notch1-CreERT2 and SMA-CreERT2 (Acta2-CreERT2) 464 
crossed to Rosa26mTmG mice are shown above each graph. e-f. Representative sections of 465 
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mammary ducts analysed by immunofluorescent staining for K5 (in red) in N1Cre/mTmG (e) and 466 
SMACre/mTmG (f) mice, 6 weeks after tamoxifen induction at P3. Lineages derived from 467 
Notch1pos or SMApos cells are marked by membrane-bound GFP in green; 2 mice for each line. 468 
Scale bars correspond to 20 μm in e-f and 10 μm in the insets. Graphs show mean ± SEM. 469 
p=0.000006 in (c) and p=0.00000000002 and 0.0003 for P0.5 and P3 respectively (d), using two-470 
tailed unpaired Welsh’s t-test. *** p<0.001. Source data are available in Supplementary Table 1.  471 
Figure 3. Notch1pos embryonic mammary cells show unipotent cell fate potential. a-b. 472 
Single Z-stacks of wholemount immunostaining of mammary trees from N1Cre/Confetti mice, 473 
induced with 0.05mg or 0.1mg of tamoxifen at E15.5, analysed 48h (a) and 2 weeks later (b). 474 
Immunostaining for K5 (white) marks basal cells. GFP (green), Cyan (blue), YFP (yellow), RFP 475 
(red) mark Notch1-derived lineages considered as unique clones derived from one ESC; 98 476 
glands in 30 embryos and 139 clones from 65 glands in 21 mice. Images were acquired as 477 
different tiles without overlap and stitched juxtaposed. Dotted line in (b) demarcates the 478 
stitching. c. Schematic diagram illustrating how 2 independent labelling events of unipotent cells 479 
(red cells, “chance bipotency”) can be confused with the unique labelling of a multipotent stem 480 
cell (red cell, “real bipotency”). d. Percentage of theoretical chance bipotency (red) compared to 481 
experimentally scored bipotency (grey) in 1-2 week-old N1Cre/Confetti mice induced with 482 
tamoxifen at indicated embryonic stages. n= 8, 5, 5, 3 independent animals induced at E12.5, 483 
E13.5, E15.5, E17.5. p values = P<0.0001, P<0.0001, P=0.5 and P=0.43. Tamoxifen dose was 484 
adjusted at each time point to reach comparable recombination efficiency, indicated by the 485 
average number of floxed colours/gland (see Methods). e. Average number of colours/gland from 486 
mice induced at indicated time points, with indicated doses, analysed after 48h (short chase, in 487 
black) or at P7 (long chase, in brown). Recombination efficiency (short chase) reflects the 488 
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number of colours found at P7 (long chase) at each tamoxifen dose (differences not significant). 489 
n=22, 32, 13, 14, 14 independent mammary glands for short times, and n=14, 9, 11, 10, 16 for 490 
long chase. f. Number of induced clonal events scored after a short chase vs number of inferred 491 
clonal events estimated from a long chase. n=12, 9, 8 biologically independent animals induced 492 
at E13.5 full dose (black dots), E15.5 diluted dose (red dots) and E15.5 full dose (blue dots). 493 
Two-tailed binomial test was applied to assess statistical differences between groups. Graphs 494 
show mean ± SEM. Source data in Supplementary Table 1. Scale bars are 100 μm or 50 μm in 495 
the magnifications in (a), 100 μm in (b). 496 
Figure 4. Notch1 activation in embryos locks multipotent stem cells into a luminal unipotent 497 
cell fate. a-c. Representative sections of N1Cre/mTmG (a, c) and N1Cre/N1ICD (b, c) induced at 498 
E13.5 and analysed 48h later, by immunofluorescent staining for the basal marker K14 (in 499 
white), the luminal marker K8 (in red) and anti-GFP (green) (a, b), or stained with hematoxylin 500 
(c). Notch1-derived lineages are labelled in green by membrane-bound GFP in the N1Cre/mTmG 501 
model (a) and by nuclear GFP in N1Cre/N1ICD mice (b). DAPI stains nuclei in blue in a, b; 2 502 
embryos per genotype. Schematic diagrams of the N1Cre/mTmG and the N1Cre/N1ICD mice are 503 
shown above panel a and b respectively. d. Representative FACS dot plot of luminal (LC) and 504 
basal cells (BC) within the GFPpos population in N1Cre/N1ICD mice 6 weeks after tamoxifen 505 
induction at E13.5; n=4 mice. e. FACS quantification of the percentage of BC within MEC (in 506 
orange) or within GFPpos cells (in green) in N1Cre/N1ICD mice induced with tamoxifen at the 507 
indicated developmental times and analysed after a 6-week chase; n=4, 6, 8, and 5 biologically 508 
independent animals induced at E13.5, E15.5, P0.5 and P3, respectively. The orange dots 509 
represent the MEC population from all mice analysed (n=23). p-values were calculated using 510 
Mann-Whitney test: p=0.0001, p<0.0001, p<0.0001 and p<0.0001, respectively. f-g. 511 
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Representative sections of N1Cre/mTmG (f) and N1Cre/N1ICD (g) induced at E13.5 and 512 
analysed 6 weeks later, by immunofluorescent staining for the basal marker SMA (in red) and 513 
anti-GFP (green). Notch1-derived lineages are labelled in green by membrane-bound GFP in the 514 
N1Cre/mTmG model (f) and by nuclear GFP in N1Cre/N1ICD (g) mice. DAPI stains nuclei in 515 
blue; 5 and 4 mice, respectively. Scale bars correspond to 20 μm or 10 μm (in magnifications). 516 
Graphs indicate average values ± SEM. ***p< 0.001. Source data are available in Supplementary 517 
Table 1.  518 
Figure 5. Notch1 dictates luminal ERαneg cell fate. a. Representative FACS dot plots of 519 
CD133 and Sca1 expression in total luminal cells (gated in LC) or GFPpos LC (gated in GFP) in 520 
N1Cre/N1ICD mice 6 weeks after tamoxifen induction at E13.5, 2 independent mice. b. FACS 521 
data quantification showing the percentage of luminal cells (LC) or of N1ICD-expressing cells 522 
(GFP) that presents Sca1 (in purple) or CD133 (in blue) expression, after a 6-week chase of 523 
N1Cre/N1ICD mice induced with tamoxifen at the indicated times. N=2, 6, 8, and 5 biologically 524 
independent animals induced at E13.5, E15.5, P0.5 and P3, respectively; n=21 in the LC graph. 525 
Graphs show mean ± SEM: 5.7±2.6 for Sca-1 and 9.9±3.2 for CD133 (E13.5), 1.7±0.3 for Sca-1 526 
and 6.5±1.4 for CD133 (E15.5), 2.8±0.8 for Sca-1 and 5.4±0.9 for CD133 (P0.5), 0.9±0.2 for 527 
Sca-1 and 7.6±1.3 for CD133 (P3). p=***p<0.001 using two-tailed unpaired Welsh’s t-test. c-d. 528 
Representative sections of N1Cre/mTmG (c) and N1Cre/N1ICD (d) mice induced at E13.5 and 529 
analysed 48h later, by immunofluorescent staining for the luminal marker K8 (in red) and the 530 
proliferation marker Ki67 (in white). Notch1-derived lineages are labelled in green by 531 
membrane-bound GFP in the N1Cre/mTmG model (c) and by nuclear GFP in N1Cre/N1ICD (d) 532 
mice. DAPI stains nuclei in blue; 2 biologically independent animals. e. Schematic diagram 533 
illustrating how Notch1 activation (N1Cre/N1ICD) imposes a luminal ERαneg cell fate to 534 
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embryonic cells (E13.5), which would otherwise be able to give rise to all mammary cell types 535 
(N1Cre/mTmG). Source data are available in Supplementary Table 1.  536 
Figure 6. Ectopic Notch1 activation switches the fate of committed mammary cells. a. 537 
Representative FACS plots and quantification of the percentage of BC within the GFPpos 538 
population of SMACre/mTmG (left panel, n=4 biologically independent animals) or 539 
SMACre/N1ICD (right panel) induced at P21 and analysed after 3 weeks (n=5 mice) or 6 weeks 540 
(n=3 mice). Graphs show mean ± SEM: 51.3±10.5 (3w chase) and 2.6±1.0 (6w chase). P-vales 541 
were calculated using two-tailed unpaired Welsh’s t-test: p= 0.0189 and p<0.0001. b. Dot plot of 542 
Sca1pos/CD133pos cells among total LC (in red) and GFPpos cells (in green) in SMACre/N1ICD 543 
mice (P21+6-week chase); n=4 biologically independent animals. c. Representative FACS plots 544 
of K5Cre/N1ICD induced at P21 and analysed after 3 weeks or 6 weeks; n=3 independent 545 
animals. d. Representative paraffin sections of mammary ducts from SMACre/mTmG (left panel) 546 
or cryosections of glands from SMACre/N1ICD (middle panel) or K5Cre/N1ICD (right panel) 547 
females induced with tamoxifen at P21 and analysed 6 weeks later by immunofluorescent 548 
staining using anti-SMA (in red) or anti-K8 (in purple) antibodies. SMA-derived lineages are 549 
labelled in green by membrane-bound GFP in the SMACre/mTmG model and by nuclear GFP in 550 
SMACre/N1ICD mice; 4 biologically independent animals. Scale bars correspond to 20 μm. e. 551 
Schematic diagram illustrating how ectopic Notch1 activation in basal cells (SMACre/N1ICD or 552 
K5Cre/N1ICD) imposes a luminal ERαneg cell fate even to already committed basal cells. ***p< 553 
0.001 and *p<0.05. Source data are available in Supplementary Table 1.  554 
Figure 7. Transcriptomic analysis of the basal to luminal switch induced by Notch1 555 
activation. a. Heatmap of Notch1 related genes, using the log(fpkm) of the average expression 556 
values (fpkm) of 3 replicates each for GFPneg and GFPpos cells. b. Transcripts with more than five 557 
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Log2 Fold Change (FC) differences obtained by RNA-seq of GFPneg and GFPpos sorted cells 558 
from SMA/N1ICD mice 72h after TAM induction; the blue bars correspond to the transcripts that 559 
are overexpressed, and the green bars indicate the transcripts that are downregulated. c. Over-560 
represented GO categories among the top genes significantly downregulated upon Notch 561 
activation. d. Gene Set Enrichment analysis (GSEA) showing the inverse correlation between 562 
genes expressed upon Notch activation (in GFPpos cells) compared to the GO signature of 563 
“Mammary_Stem_Cell_Up”. A set of 12984 genes from three replicates was pre-ranked based on 564 
log2 fold changes. e. Model of the differentiation hierarchy during embryonic mammary gland 565 
development. Multipotent mammary stem cells are present in the early mammary placode, but at 566 
E12.5 some lineage restriction starts to occur, as unipotent luminal or basal precursor can be 567 
found at a frequency of about 30-40%, while the remaining MaSCs are still multipotent. Starting 568 
at embryonic day E15.5, no statistically discernable multipotency can be observed, suggesting 569 
that prenatal growth and branching of the mammary gland is supported by unipotent luminal or 570 
basal progenitors. At P0, an additional degree of fate restriction establishes two independently 571 
sustained luminal lineages, ERpos and ERneg luminal cells. Notch signalling prevents the 572 
generation of basal precursors during mammary embryogenesis and blocks ERpos cell fate 573 
specification. 574 
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Online Methods 1 
Mice 2 
N1CreERT2 23, SMA-CreERT2 43 and K5-CreERT2 mice 44 were crossed to the double fluorescent 3 
reporter Rosa26mT/mG 27, to the multicolour R26R-Confetti mouse reporter33, or to a conditional 4 
gain-of-function Notch1 mutant mouse (Rosa-N1IC-IRES-nGFP)36. Reporter expression was 5 
induced in N1CreERT2 or SMA-CreERT2 females by intraperitoneal tamoxifen injection of pregnant 6 
females at E11.5, E12.5, E13.5, E15.5 or E17.5, followed by C-section at E19.5 due to delivery 7 
failure caused by tamoxifen. Newborn pups were adopted by foster mothers. Postnatal induction 8 
was done at P0 and P3 by injecting lactating mothers, and at P10, P15 and P21 by injecting the 9 
pups. Females were injected with 0.1mg/g of mouse body weight of tamoxifen free base 10 
(Euromedex). For experiments using the Confetti reporter, the dose of tamoxifen was adjusted to 11 
0.05 mg/g and to 2µg/g of mouse body weight for injections at E15.5 and E17.5 respectively, to 12 
achieve the same frequency of recombination (2-2.5 average floxed colours per gland). For each 13 
experiment, four mammary glands of at least three mice were analyzed. No fluorescence was 14 
observed in non-induced mice. For EdU (5-ethynyl-2'-deoxyuridine) labelling experiments, mice 15 
were injected intra-peritoneally with 20mg/kg bodyweight of EdU 2 hours prior to isolation of 16 
mammary glands. We have exclusively analyzed female mice and no randomization methods 17 
were performed. 18 
Ethics Statement 19 
All studies and procedures involving animals were in strict accordance with the recommendations 20 
of the European Community (2010/63/UE) for the Protection of Vertebrate Animals used for 21 
Experimental and other Scientific Purposes. The project was specifically approved by the ethics 22 
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committee of the Institut Curie CEEA-IC #118 and approved by the French Ministry of Research 23 
with the reference #04240.03. We comply with internationally established principles of 24 
replacement, reduction, and refinement in accordance with the Guide for the Care and Use of 25 
Laboratory Animals (NRC 2011). Husbandry, supply of animals, as well as maintenance and care 26 
of the animals in the Animal Facility of Institut Curie (facility license #C75–05–18) before and 27 
during experiments fully satisfied the animal’s needs and welfare. Suffering of the animals has 28 
been kept to a minimum; no procedures inflicting pain have been performed. 29 
Wholemount and two-dimensional immunostaining 30 
For whole mount staining of N1Cre/confetti animals, glands from mice at 7 or 15 days of age 31 
were dissected ad incubated with 2.5mg/ml collagenase (C0130, Sigma) and 300μg/ml 32 
hyaluronidase (Sigma H3506) for 30 min to 1 hour at 37ºC under gentle shaking. Intact glands 33 
were washed in PBS and fixed with 4% PFA for 2 hours at room temperature. For Supplementary 34 
Fig. 2, glands from 6-week old mice were incubated in 600 U/ml collagenase and 200 U/ml 35 
hyaluronidase for 1 hour at 37ºC under gentle shaking. Tissue fragments were washed in PBS by 36 
serial pulse centrifugations at 1200 rpm and fixed with 4% PFA for 20 min at room temperature. 37 
Two-dimensional staining was performed with 5 or 30 μm sections. Freshly dissected mammary 38 
glands were fixed in 4% paraformaldehyde for 2 hours and embedded in paraffin for animals 39 
crossed to the Rosa26mT/mG reporter, or in optimal cutting temperature (OCT) medium (VWR 40 
International) for animals crossed to Rosa-N1IC-ires-nGFP. Sections were stained according to 41 
Rodilla et al. 11. Antibodies used were chicken anti-GFP (1:1000 dilution, Ab13970, Abcam), 42 
rabbit anti-GFP (1:800 dilution, a generous gift from Monique Arpin), human anti-GFP (1:400 43 
dilution, hVHH anti-GFP hFC, Recombinant Antibody Platform, Institut Curie), rabbit anti-K5 44 
(1:800 dilution PRB-160P, Covance), mouse anti-SMA (1:800 dilution, #A2547, SIGMA), rabbit 45 
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anti-K8 (1:800 dilution ab53280, Abcam), mouse-anti-K8 (1:400 dilution MMS-162P, Covance), 46 
rat anti-K8/K18 (1:300 dilution TROMA-1, DSHB), mouse anti-ERα (1:200 dilution M7047; 47 
Dako); mouse anti-p63 (1:600 dilution Ab3239, Abcam), rabbit anti-K14 (1:1000 dilution, 48 
ab181595, Abcam) and rabbit anti-cleaved Caspase-3 (1:200 dilution, 9661, Cell Signaling). 49 
Fluorochrome-conjugated secondary antibodies included AlexaFluor 488-conjugated anti-50 
chicken IgG, Cy3-conjugated anti-rabbit IgG and Cy3- conjugated anti-mouse IgG for paraffin 51 
sections, and AlexaFluor 488-conjugated anti-rabbit IgG, Cy5-conjugated anti-rabbit and anti- 52 
mouse IgG, Cy2 and Cy3-conjugated anti-human IgG, and Cy3 and Cy5 anti-rat IgG for frozen 53 
sections. It is noteworthy that after paraffin embedding, the red Tomato signal is completely lost, 54 
as well as the GFP signal; for this reason, when we analyzed paraffin-embedded sections we 55 
always used anti-GFP antibodies and we could safely use Cy3-conjugated secondary antibodies, 56 
as no signal in the red channel was evident. All secondary antibodies were used at 1:1000 57 
dilutions and were purchased from Molecular Probes and Jackson ImmunoResearch Laboratories, 58 
Inc. EdU detection was performed using the Click-iT EdU Alexa Fluor 647 Imaging Kit 59 
(Molecular Probes), according to manufacturer’s instructions. At least three independent 60 
investigators have counted the coloured clones generated in the wholemount experiments, and 61 
two investigators were blinded. The number of counted clones was: 50 clones in 24 glands from 62 
8 animals induced at E12; 33 clones in 14 glands from 5 animals induced at E13; 45 clones in 17 63 
glands from 7 animals induced at E15, and 45 clones in 17 glands from 3 animals induced at E17. 64 
RNAscope in situ hybridisation 65 
RNA in situ hybridisation for mouse Notch1 (404641-C1) was performed manually according to 66 
the manufacturer’s instructions (Advanced Cell Diagnostics, Inc.). In brief, 7-μm 67 
paraformaldehyde-fixed, OCT-embedded frozen tissue sections were pre-treated with heat and 68 
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protease before hybridisation with the target oligonucleotide probes. Preamplifier, amplifier and 69 
alkaline-phosphatase-labelled oligonucleotides were then hybridised sequentially, coupled with a 70 
fluorescent conjugate. Each sample was quality controlled for RNA integrity with an RNAscope 71 
probe specific to PolR2A RNA (320881) and for background with a probe specific to bacterial 72 
dapB RNA (320881). Specific RNA staining signal for Notch1 was identified as red punctate 73 
dots. Samples were counterstained with antibodies to K8 and GFP and with DAPI. The 74 
experiment was performed on 4 embryos from three different mothers for each probe. 75 
Microscopy and image acquisition 76 
For image acquisition of stained sections, we used a PLAN APO 63x/1.4NA objective on an 77 
upright spinning disk (CSU-X1 scan-head from Yokogawa) microscope (Carl Zeiss, Roper 78 
Scientific France), equipped with a CoolSnap HQ2 CCD camera (Photometrics). Images were 79 
captured using Metamorph. Confetti images were acquired using a laser scanning confocal 80 
microscope (LSM780 or LSM880, Carl Zeiss) with a LD LCI PLAN-APO 25× / 0.8NA OIL 81 
objective. Acquisition settings were the following: zoom 0.6, xy pixel size 554nm, spectral 82 
emission filters (bandwidth): 414-485nm, 490-508nm, 535-553nm, 588-615nm, 641-735nm and 83 
laser wavelengths: 405, 488, 514, 561 and 633nm. Wholemount images were acquired in 84 
different tiles and stitched without overlap by juxtaposition using the Zeiss software Zen Black 85 
14.0.8.201. Image processing was performed using Fiji Software, version 2.0.0.  86 
Mammary gland dissociation and Flow cytometry 87 
Single cell dissociation was performed through enzymatic digestion with 600 U/mL collagenase 88 
(Sigma) and 200 U/mL hyaluronidase (Sigma) for 1 h at 37°C. Cells were further dissociated in 89 
TrypLE (Gibco) for 3 min, in 5 mg/mL dispase (Roche) and 0.1 mg/mL DNase I (Sigma) for 5 90 
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min, and then in 0.63% NH4Cl and filtered through a 40 μm cell strainer to obtain a single cell 91 
preparation for FACS. Cell labelling, and flow cytometry were performed as previously 92 
described in Rodilla et al., 2015. Dead cells (DAPI+), and CD45+/CD31+/Ter119+ (Lin+) non-93 
epithelial cells were excluded before analysis using LSRII or FACS ARIA flow cytometers (BD). 94 
The following antibodies were used in 1:100 final concentration: biotin anti-CD133 (BioLegend), 95 
PE/Cy7 anti-mouse CD24 (BioLegend), PerCP/Cy5.5 anti-mouse Sca-1 (BioLegend), 96 
AlexaFluor700 anti-mouse/rat CD29 (BioLegend), PE anti-mouse CD49b (BioLegend); lineage 97 
markers: APC anti-mouse CD31 (BioLegend), APC anti-mouse Ter119 (BioLegend), APC anti-98 
mouse CD45 (BioLegend); APC/Cy7 Streptavidin; isotype controls: PE rat IgM (BioLegend), 99 
PerCP/Cy5.5 rat IgGa (BioLegend). The purity of sorted populations was about 95%. The results 100 
were analyzed using FlowJo software and the data processing with Prism-graphpad. 101 
RNA Sequencing 102 
Total RNA was extracted from basal GFP+ and GFP- populations from mammary glands of 103 
SMACre/N1ICD mice, using Qiagen RNeasy kit according to manufacturer’s instructions. 104 
Library preparation was performed at Integragen (http://www.integragen.com/). All DNA 105 
libraries were quantified by qPCR. Only DNA with adapters ligated to both ends could be 106 
measured, as only these fragments can be amplified to generate material for sequencing. This 107 
quantification was able to qualify the DNA library, which was then ready to generate clusters to 108 
the expected density. The library was sequenced on paired end 2x75b run on the Illumina 109 
HiSeq4000. Image analysis and base calling was performed using Illumina Real Time Analysis 110 
(2.7.7) with default parameters. 111 
RNA Sequencing analysis 112 
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Quality control and raw sequences cleaning 113 
Quality of reads was assessed for each sample using FastQC 114 
(http://www.bioinformatics.babraham.ac.uk/projects/fastqc/). Raw reads were trimmed to remove 115 
the first three bases of the first read using Cutadapt tool (Martin et al., 2011). 116 
Sequence alignment and quantification of gene expression 117 
A subset of 500,000 reads from each Fastq file was aligned to the reference mouse genome 118 
mm10 with TopHat2 45 to determine insert sizes with Picard  119 
(https://broadinstitute.github.io/picard/). Full Fastq files were aligned to the reference mouse 120 
genome mm10 with TopHat2 (-p 24 -r 150 -g 2 --library-type fr-secondstrand)45. We removed 121 
reads mapping to multiple locations. We quantified gene expression using transcriptome 122 
annotations from Gencode (vM14). We used HTSeq 46 to obtain the number of reads associated 123 
to each gene in the Gencode database (restricted to protein-coding genes, antisense and 124 
lincRNAs). We used the Bioconductor DESeq package47 to import raw HTSeq counts for each 125 
sample into R statistical software and extract the count matrix. After normalizing for library size, 126 
we normalized the count matrix by the coding length of genes to compute FPKM scores (number 127 
of fragments per kilobase of exon model and millions of mapped reads). 128 
Differential expression analysis 129 
Only genes expressed in at least one sample (FPKM≥0.1) were considered for downstream 130 
analysis. The Bioconductor Limma package48 was used to test for differential expression and a q-131 
value threshold of ≤0.15 was applied to define differentially expressed genes. 132 
Gene set enrichment analysis 133 
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Hypergeometric tests were used to identify overrepresented gene sets from the MSigDB v5 134 
database49 adjusted for mouse organism based on The Jackson Laboratory Human and Mouse 135 
Homology and provided by The Walter and Eliza Hall Institute of Medical Research 136 
(http://bioinf.wehi.edu.au/software/MSigDB/). P-values were corrected for multiple testing with 137 
the Benjamini-Hochberg procedure. GSEA v3.0 was used to generate Fig. 7d and calculate the 138 
enrichment score. 139 
Statistical analysis of chance bipotency 140 
In order to distinguish “real” bipotency of individual mammary progenitors and “chance 141 
bipotency” associated with the random and simultaneous labelling of unipotent basal and luminal 142 
progenitors of the same colour with a given mammary gland, we resorted to a statistical analysis 143 
and numerical simulations of random clonal induction.  144 
Description of the method 145 
We tested the null hypothesis that all bipotent events could be explained by “chance bipotency” 146 
in a purely unipotent framework, by calculating for each time point the probability of chance 147 
bipotency, which depends on three experimentally measured parameters10: 1/ the induction rate μ 148 
(fitted via the average number of confetti colours in a given gland, see Fig. S5g-h), 2/ the relative 149 
chimerism (i.e. the relative frequency of RFP, GFP, CFP and YFP cells), 3/ the relative induction 150 
of basal vs. luminal cell (assessed by assuming that progenitors are unipotent and counting the 151 
relative probability of finding luminal vs. basal clones of a given colour in a gland). These three 152 
parameters are integrated in the simulation in the following way: 153 
1/ We ran stochastic simulation of a given mammary gland, numerically simulating the random 154 
induction of n cell on average per gland (giving rise to a Poisson distribution of number of cells 155 
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induced), with the average number of event per gland fitted as described above from the average 156 
number of colours in a given gland. For each time point, we ran n=1.000.000 simulations, 157 
corresponding each to a single mammary gland), in order to be able to get global statistics, but 158 
also detailed statistics on the “chance potency” of each individual confetti colour.  159 
2/ We then choose the confetti colour of each of the nlab labelled cells in a given gland, as a 160 
stochastic process where the probability of each colour corresponds to the experimentally 161 
observed global colour ratio. 162 
3/ We finally choose the fate (basal or luminal) of each of the nlab labelled cells in a given gland, 163 
again as stochastic process (binomial distribution), where the probability of each outcome is 164 
parameter 3 mentioned above. One should note that, as we explore the “unipotent” null 165 
hypothesis here, mixed basal/luminal clones are counted here as two separate unipotent clones to 166 
calculate the basal/luminal induction ratio. However, as discussed below and on Extended Data 167 
Fig. 5l-m, we subsequently validated parameter 3 further to show that the results were also 168 
consistent when considering the unipotent clones only. 169 
As mentioned, we thus measured all three parameters for each time point, and ran numerical 170 
simulations using the respective parameters for each time point. In particular, as the induction 171 
frequency (parameter 1) varied significantly between different time points, and as this parameter 172 
is particularly crucial to set the probability of “chance bipotency” (for very rare inductions, the 173 
probability is close to zero; for mosaic labelling, the probability is close to 100%), we adjusted 174 
the induction frequency at each time point in the simulations to match the respective average 175 
number of colours. For instance, at E15.5 (0.05 mg/g tamoxifen), we found 2.2 colours on 176 
average, which translated into an average induction frequency of 4.2 independent precursors per 177 
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mammary gland. It should be noted that we excluded from the analysis the rare clones containing 178 
a single cell, as this leaves the issue of potency undetermined.   179 
Controls to assess method robustness.  180 
In Supplementary Fig. 5g-h, we display a sensitivity analysis for E15.5 parameters, where we 181 
varied the induction frequency (parameter 1), to show its dependency on 1/ the average number 182 
of colours per gland, and 2/ the fraction of “chance” bipotency. As discussed in the legend of 183 
Supplementary Fig. 5, this sensitivity analysis was performed using the relative chimerism 184 
extracted from either the E12 or E17 dataset, to show that 1/ the balance of the four confetti 185 
colours was not significantly modified between the first and last induction time points used in 186 
this study, 2/ the predicted “chance” potency depended only very weakly on the time point 187 
chosen for the values of the relative colour frequencies (discrepancies increase at very high 188 
inductions doses, given the fact that the number of colours becomes very sensitive on the 189 
probability of CFP induction, which is rare and thus associated with high variance and 190 
uncertainty). 191 
Moreover, as this analysis reveals parameter 1 to be the most crucial for the prediction of change 192 
bipotency, we sought to experimentally validate the values that we inferred from long-term 193 
tracings. We thus repeated the tracings using the same doses, but collecting samples 48h after 194 
induction, in order to allow enough time for the recombination to occur, but not enough for large-195 
scale clonal dispersion. We also tested both Tamoxifen doses at E15.5, to validate the higher 196 
induction we inferred for 0.1mg at E15.5. Importantly, both doses as E15.5 and the E13.5 time 197 
point displayed excellent agreement (Fig. 3f) between the measured clonal induction on short-198 
term tracings (number of labelled singlets or doublets per mammary gland) and the inferred 199 
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clonal induction on long-term tracings. This validates both the inference method and the 200 
predictions on change potency. Of note, we tried to apply the same method for E17.5+48h short-201 
term tracings, but found that clones were already dispersed on long distances in the gland, due to 202 
the several steps of branching at this point, which made it impossible to assess clones reliably.  203 
Next, we sought to validate further our estimation of parameter 3, which is also important for the 204 
prediction of chance bipotency (in the limit of pure induction of luminal cells, there would be 205 
zero chance bipotency). We therefore re-plotted the observed vs predicted potencies for E15 and 206 
E17 inductions, but segregating unipotent basal and unipotent luminal in separate categories. This 207 
provides a safety check to verify that the parameter 3 also predicts well the ratio of basal to 208 
luminal unipotent clones (where the cell of origin is un-ambiguous). Indeed, if for instance, basal 209 
cells where much more bipotent than luminal cells, our theory could over-estimate basal 210 
unipotency, and our estimate of Parameter 3 could be biased by basal, but not luminal, bipotency. 211 
Importantly, we did not find statistical differences between experimental and predicted 212 
distributions (Supplementary Figure 5l-m, P=0.25 at E15, P=0.79 at E17, Chi-squared tests), 213 
demonstrating robustness of our results. At E15, one should note that the theory slightly over-214 
estimates basal potency, although one would need much higher statistics to test if there really is a 215 
small basal population retaining residual E15 bipotency. At E17, the theory predicts nearly 216 
perfectly both basal and luminal unipotency. 217 
Finally, as an additional test of the method, we sought to test whether the stochastic induction 218 
modelled reproduced well the experimental distribution of number of colours per gland (as we 219 
only used the average number of colours per gland). We thus computed the predicted value from 220 
the same simulations as above, and found a good quantitative agreement with the data, validating 221 
 11
our hypothesis of stochastic (Poisson) induction of labelled cells in different glands 222 
(Supplementary Fig. 5i-k) at all time points. 223 
Results on “chance bipotency”. 224 
To statistically test the validity of the null, unipotent hypothesis, at each time point, we then 225 
compared the theoretical probability of finding “chance bipotency” to its experimental 226 
counterpart. Given that there are only two categories (“unipotent” or “bipotent”), we used two-227 
tailed binomial tests to calculate P-values associated with the hypothesis at each time point 228 
(except for Supplementary Fig. 5l-m which have three categories and where we used a chi-229 
squared test). Accordingly, on the graphs of Fig. 3d and Supplementary Fig. 5b-m, all error bars 230 
are calculated as the standard deviation of the binomial distributions underlying the 231 
experimentally measured probabilities – although this gives very similar standard deviations to 232 
the ones computed based on biological replicates, see Supplementary Fig. 5a. As discussed in the 233 
main text, we find very significant bipotency at E12.5 and E13.5 (P<0.0001), with more than half 234 
of the observed bipotency being “real”, rather than occurring by chance. On the other hand, we 235 
do not find statistically significant “real” bipotency at E15.5 and E17.5 (P=0.5 and P=0.43). Of 236 
note, in the findings reported in the main text, we used lower and lower doses of Tam as a 237 
function of time, in order to maintain the relative induction at a constant level (as monitored by 238 
the average number of colours in Fig. 3d). This behaviour is logical, as the number of cells in a 239 
given mammary gland increases steadily as a function of time, so that the number of floxed cells 240 
per gland is expected to increase throughout embryogenesis, requiring lower and lower doses for 241 
a clonal analysis. Nevertheless, for the sake of completeness, we also analysed E15.5 glands 242 
induced at a higher dose of 0.1mg/g of tamoxifen (i.e. the E12.5/E13.5 dose). Although the 243 
fraction of observed bipotency is much higher than for the 0.05 mg/g tamoxifen experiment, the 244 
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difference is fully in line with the theoretical prediction for this induction dose (3.3 colours for 245 
0.1mg tamoxifen vs. 2.2 colours for 0.05mg), as shown in Supplementary Fig. 5b. Remarkably, 246 
we still could not find statistically significant differences between observed and “chance” 247 
bipotency (P=0.12, two-tailed binomial test). Finally, we challenged our statistical analysis by 248 
testing whether our results were consistent when examining separately each confetti colour. CFP 249 
was so rare that only 1 or 2 clones could be observed at each time point, preventing any robust 250 
statistical test on this colour. However, YFP, RFP and GFP are still recombined with consistently 251 
different efficiencies, with YFP being the rarest of the three. This provided a platform to test our 252 
hypothesis of “chance bipotency”, as one would predict a higher probability of “chance 253 
bipotency” for GFP/RFP than for YFP. Supplementary Fig. 5b-f shows observed vs “chance” 254 
bipotency percentages for each three colours, at all four time points. Importantly, we find 255 
consistent results with the global results: at E15.5 and E17.5, we do not find any colour in which 256 
the differences between observed and “chance” bipotency are statistically different (P>0.3 in all 257 
cases). Importantly, the observed and “chance” potencies were consistently higher for more 258 
represented colours, and lower for less frequent colours. Similarly, at E12.5 and E13.5, we found 259 
consistent statistically significant (and large) excesses in observed bipotency compared to 260 
“chance” (P<0.05 in all cases, except for E13 RFP, P=0.11, which could be due to the relatively 261 
small number of RFP events – 11 in total at E13).  262 
Code availability statement 263 
Computer codes used in this study are available upon request. 264 
Statistics and Reproducibility 265 
Experiments were performed in biological and technical replicates as stated. Each experiment 266 
was repeated independently at least two times, with similar results. For each experiment, we have 267 
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used at least n=2 animals, and experiments with at least n=4 were used to calculate the statistical 268 
value of each analysis. All graphs show mean ± SEM. Statistical analysis to compare differences 269 
between groups implied two-tailed unpaired Welsh’s t-tests, unless otherwise stated.  270 
Data availability 271 
RNA sequencing data that support the findings of this study have been deposited in the Gene 272 
Expression Omnibus (GEO) under accession code GSE105432. Source data have been provided 273 
as Supplementary Table 1. All other data supporting the findings of this study are available from 274 
the corresponding author on reasonable request. 275 
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